It was announced on November 20th, 2017 that the European Medicines Agency (EMA) will relocate to Amsterdam. This agency plays a crucial role in the development and authorization of orphan medicines in Europe. Orphan medicines are medicinal products intended for the diagnosis, prevention or treatment of rare diseases. Wishing them…











